SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-08-074056
Filing Date
2008-12-02
Accepted
2008-12-02 08:00:42
Documents
10
Period of Report
2008-12-02
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a08-29570_18k.htm 8-K 26602
2 EX-99.1 a08-29570_1ex99d1.htm EX-99.1 38628
3 EX-99.2 a08-29570_1ex99d2.htm EX-99.2 14073
4 GRAPHIC g295701moi001.gif GRAPHIC 104761
5 GRAPHIC g295701moi002.gif GRAPHIC 187373
6 GRAPHIC g295701moi003.gif GRAPHIC 107701
7 GRAPHIC g295701moi004.gif GRAPHIC 88243
8 GRAPHIC g295701moi005.gif GRAPHIC 77719
9 GRAPHIC g295701moi006.gif GRAPHIC 100024
10 GRAPHIC g295701moi007.gif GRAPHIC 89478
  Complete submission text file 0001104659-08-074056.txt   1122570
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 081223824
SIC: 2834 Pharmaceutical Preparations